TABLE 1.

Summary of reviewed studies dealing with BACTEC MGIT 960 systema

DrugAuthors (reference)YrCC (μg/ml)No. of:Sens.Spec.PPVNPVDOR
Tested strainsTPFNFPTN
SMArdito et al. (5)20011.078740041.001.001.001.007.20
4.078770011.001.001.001.006.14
Bemer et al. (6)20021.01107680260.901.001.000.766.17
4.0341240180.740.970.960.804.63
Tortoli et al. (38)20021.013312010120.991.001.000.927.61
Scarparo et al. (33)20041.01006224320.970.890.940.945.51
4.01007520230.971.001.000.927.26
INHArdito et al. (5)20010.1786010170.981.001.000.947.25
0.478730051.001.001.001.007.39
Bemer et al. (6)20020.11108130260.961.001.000.907.12
Tortoli et al. (38)20020.113311130190.971.001.000.867.12
Johansen et al. (16)20040.422214320770.981.001.000.979.09
Scarparo et al. (33)20040.11005120470.961.001.000.967.58
0.41005630410.951.001.000.937.20
  • a Data are reported by individual drug. DORs are expressed as logarithms. TP, true positive; FN, false negative; FP, false positive; TN, true negative; Sens., sensitivity; Spec., specificity; PPV, positive predictive value; NPV, negative predictive value.